Loading clinical trials...
Loading clinical trials...
The primary endpoint for this study is the clinical response after 12 weeks of treatment, defined as a change in total score from baseline depressive symptoms as measured by the Beck Depression Invent...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lundbeck Italia S.p.A.
Collaborators
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT07020572 · Depressive Symptoms
NCT07536022 · Parkinson's Disease
NCT07644013 · Multiple System Atrophy, Parkinson's Disease, and more
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
IT010
Cagliari
IT007
Chieti
IT004
Genova
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions